Fresenius Medical reported better-than-expected quarterly results with earnings per share of $0.66 and revenue of $5.60 billion, surpassing analyst estimates. The company maintains strong financial health, reflected in solid solvency and liquidity ratios, including a debt-to-equity ratio of 0.83 and a current ratio of 1.20. Despite a slight price target adjustment by Truist Financial, the stock still shows potential upside. These results reinforce Fresenius Medical's position in the competitive dialysis care market and indicate continued stability for investors.
Evercore ISI increased its price target for Shopify to $175, reflecting an 18.51% potential upside following the company's strong Q2 results. Shopify reported a 34% revenue increase to $3.6 billion and an EPS of $0.42, beating estimates. Key growth d...
Oppenheimer downgraded Insulet Corporation from Outperform to Perform following the company's strong Q2 earnings report, which showed 23% revenue growth and improved profitability metrics. Despite the solid quarterly results driven by demand for its ...
TAT Technologies Ltd. reported quarterly earnings of $0.35 per share, beating analyst estimates by 25%, driven by robust aerospace demand and a record $615 million backlog. Revenue rose 22.8% year-over-year to $52.94 million, surpassing expectations ...
SenesTech reported significant growth in Q2 2026 with its online subscriber base more than doubling and e-commerce revenue rising 186% from Q1. Despite this growth, the company expects an EPS loss of $0.37 on revenues around $601,500, reflecting ongo...
Concentrix and Currys have won the NiCE 2026 International CX Excellence Award for their innovative transformation of customer engagement using NiCE CXone technology. This solution unified customer interactions across all channels, improving satisfac...
